Compass Therapeutics, Inc. participated in Citi's Biopharma Back to School Conference in Boston.

1 report, 1 independent Updated Aug 26

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Boston

How it developed

Newest first. Tap a step to see who reported it.

Jun 7Compass Therapeutics, Inc. received an 'Outperform' rating from Raymond James following Q2 results, related to their drug Tovecimig targeting Delta-like ligand 4.Sub-event
Aug 26Compass Therapeutics participated in Citi's Biopharma Back to School Conference in Boston.1 source
- GlobeNewswire

Keep exploring

Part of

Citi's conference is held in Boston, MA. All 1 developments

The entities involved

Boston
capital and largest city of Massachusetts, United States
- The Federal Aviation Administration is managing air traffic operations at Boston Logan Airport.Mon 17:34
- Modulate leverages benchmarks set by Hugging Face.Mon 17:24

Related events

Ligand Pharmaceuticals Incorporated participated in investor conferences in New York and Boston on August 26, 2026.Aug 26

Coverage

Newest first; wire copies grouped

Aug 26GlobeNewswireCompass Therapeutics to Participate in Upcoming September Investor Events BOSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-f